rs397515509
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4BP6_Very_StrongBS1BS2
The ENST00000361390.2(MT-ND1):c.719C>T(p.Thr240Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 8/11 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T240A) has been classified as Likely benign.
Frequency
Consequence
ENST00000361390.2 missense
Scores
Clinical Significance
Conservation
Publications
- mitochondrial diseaseInheritance: Mitochondrial Classification: DEFINITIVE Submitted by: ClinGen
- Leigh syndromeInheritance: Mitochondrial Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ND1 | unassigned_transcript_4789 | c.719C>T | p.Thr240Met | missense_variant | Exon 1 of 1 | |||
| TRNI | unassigned_transcript_4790 | c.-238C>T | upstream_gene_variant |
Ensembl
Frequencies
Mitomap
ClinVar
Submissions by phenotype
Leigh syndrome Benign:1
The NC_012920.1:m.4025C>T (YP_003024026.1:p.Thr240Met) variant in MTND1 gene is interpretated to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes: BA1 -
not provided Benign:1
- -
Leber optic atrophy Other:1
- -
Computational scores
Source: